Daphne Collias

456 total citations · 1 hit paper
7 papers, 310 citations indexed

About

Daphne Collias is a scholar working on Molecular Biology, Business and International Management and Ecology. According to data from OpenAlex, Daphne Collias has authored 7 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Business and International Management and 1 paper in Ecology. Recurrent topics in Daphne Collias's work include CRISPR and Genetic Engineering (7 papers), RNA and protein synthesis mechanisms (2 papers) and Innovation and Socioeconomic Development (2 papers). Daphne Collias is often cited by papers focused on CRISPR and Genetic Engineering (7 papers), RNA and protein synthesis mechanisms (2 papers) and Innovation and Socioeconomic Development (2 papers). Daphne Collias collaborates with scholars based in Germany, United States and Israel. Daphne Collias's co-authors include Chase L. Beisel, Scott P. Collins, Jennie R. Fagen, Atul K. Singh, Vincent Noireaux, Ryan Marshall, Till Strowig, Jin Liu, Éva Almási and Rebecca Slotkowski and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Science Advances.

In The Last Decade

Daphne Collias

7 papers receiving 308 citations

Hit Papers

CRISPR technologies and the search for the PAM-free nuclease 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daphne Collias Germany 7 292 47 37 34 27 7 310
Megumu Mabuchi United States 12 336 1.2× 59 1.3× 22 0.6× 23 0.7× 17 0.6× 14 357
Gytis Druteika Lithuania 6 263 0.9× 45 1.0× 14 0.4× 38 1.1× 26 1.0× 6 289
Zhipeng Wang China 9 225 0.8× 59 1.3× 30 0.8× 17 0.5× 22 0.8× 18 330
André Plagens Germany 9 305 1.0× 60 1.3× 42 1.1× 23 0.7× 26 1.0× 12 351
Haopeng Yu China 12 485 1.7× 65 1.4× 22 0.6× 123 3.6× 36 1.3× 22 533
Sushmitha Paulraj Lithuania 4 385 1.3× 62 1.3× 43 1.2× 91 2.7× 59 2.2× 5 398
Yanwu Huo China 6 218 0.7× 61 1.3× 34 0.9× 22 0.6× 23 0.9× 8 295
Sae Okazaki Japan 8 470 1.6× 61 1.3× 34 0.9× 47 1.4× 46 1.7× 10 502
Rimantė Žedaveinytė United States 5 511 1.8× 87 1.9× 46 1.2× 81 2.4× 69 2.6× 7 545
Baskaran Anand India 13 322 1.1× 76 1.6× 28 0.8× 31 0.9× 9 0.3× 17 347

Countries citing papers authored by Daphne Collias

Since Specialization
Citations

This map shows the geographic impact of Daphne Collias's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daphne Collias with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daphne Collias more than expected).

Fields of papers citing papers by Daphne Collias

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daphne Collias. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daphne Collias. The network helps show where Daphne Collias may publish in the future.

Co-authorship network of co-authors of Daphne Collias

This figure shows the co-authorship network connecting the top 25 collaborators of Daphne Collias. A scholar is included among the top collaborators of Daphne Collias based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daphne Collias. Daphne Collias is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Jiao, Chunlei, et al.. (2024). TracrRNA reprogramming enables direct PAM-independent detection of RNA with diverse DNA-targeting Cas12 nucleases. Nature Communications. 15(1). 5909–5909. 13 indexed citations
2.
Miele, Solange, Moran G. Goren, Yanying Yu, et al.. (2024). Systematic interrogation of CRISPR antimicrobials in Klebsiella pneumoniae reveals nuclease-, guide- and strain-dependent features influencing antimicrobial activity. Nucleic Acids Research. 52(10). 6079–6091. 9 indexed citations
3.
Collias, Daphne, et al.. (2023). Systematically attenuating DNA targeting enables CRISPR-driven editing in bacteria. Nature Communications. 14(1). 680–680. 27 indexed citations
4.
Collias, Daphne & Chase L. Beisel. (2021). CRISPR technologies and the search for the PAM-free nuclease. Nature Communications. 12(1). 555–555. 191 indexed citations breakdown →
5.
Collias, Daphne, Ryan T. Leenay, Rebecca Slotkowski, et al.. (2020). A positive, growth-based PAM screen identifies noncanonical motifs recognized by the S. pyogenes Cas9. Science Advances. 6(29). eabb4054–eabb4054. 22 indexed citations
6.
Collias, Daphne, Ryan Marshall, Scott P. Collins, Chase L. Beisel, & Vincent Noireaux. (2019). An educational module to explore CRISPR technologies with a cell-free transcription-translation system. PubMed. 4(1). ysz005–ysz005. 25 indexed citations
7.
Fagen, Jennie R., Daphne Collias, Atul K. Singh, & Chase L. Beisel. (2017). Advancing the design and delivery of CRISPR antimicrobials. Current Opinion in Biomedical Engineering. 4. 57–64. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026